Intuitive’s Robinson shares a deeper look into the design challenges of a multi-port surgical system
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
3d ago
In this episode of IntuitiveTalks, David Robinson, VP of Multiport Design Engineering at Intuitive, delves into the intricacies of the company's multiport system, a flagship product that has been continuously refined since its inception. Robinson discusses the development of the surgical stapler and the surgical table, two key system components, and highlights the unique challenges faced in designing a robotic surgical stapler and ensuring the surgical table could move in sync with the robotic arms for precise operations. The episode also explores the evolution of the multiport system and how ..read more
Visit website
FAST FIVE: Bayer is making a digital health play, startup Ezra wants to make a 15-min MRI using AI
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
4d ago
The FDA clearance obtained by startup Ezra for its AI technology marks a significant milestone for the company. Ezra wants to reduce MRI times to 15 minutes. Hear more from Fast Five hosts Danielle Kirsh and Chris Newmarker as they outline what the technology does and its potential to streamline MRI scans. B. Braun recently launched its DoseTrac Enterprise infusion management software for hospital systems. The technology can connect up to 40,000 different infusion pumps at once. Get the details from Newmarker about how the technology helps hospitals reach significant results and how the mobili ..read more
Visit website
FAST FIVE: iRhythm’s FDA warning letter, Masimo management and activist investor trade blows
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
4d ago
The global release of Exactech's next-generation GPS Shoulder system marks an important milestone in shoulder arthroplasty. The launch, taking place in EMEA and APAC countries, follows the first surgery in the United Arab Emirates earlier this month. Fast Five Hosts Danielle Kirsh and Chris Newmarker share details about the orthopedic device and what doctors think of the system. With a new CE mark, Establishment Labs has completed a full transition of all currently marketed Motiva implants and tools, as well as the company’s quality management systems, to be in compliance with the new European ..read more
Visit website
How Anika Therapeutics is using M&A and R&D to evolve into a global joint preservation business
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
1w ago
In this episode, Cheryl R. Blanchard, Ph.D., CEO of Anika Therapeutics, explains how the company is morphing from a biomaterials into a joint preservation business. In an interview with Tom Salemi, editorial director of DeviceTalks, Blanchard points to collaboration she had with biomedical greats over her career, including a formative connection with Ray Elliott, the former CEO of Zimmer. Today, through sizable M&A and internal development, Anika is building a portfolio of ortho biomaterials and new joints that gives is more shots on net. Blanchard explains how Anika’s opportunity has grow ..read more
Visit website
Straight from DeviceTalks Boston: BD CEO Tom Polen on pandemic, M&A and successful succession plans
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
2w ago
This episode of DeviceTalks Weekly brings you DeviceTalks Boston’s opening keynote conversation with Tom Polen, CEO, President and Chairman of Becton Dickinson. In the conversation, Polen recounts his tragic first encounter with the medical device industry, his path into medtech and the CEO’s chair, and the work BD put into helping the world survive the COVID-19 pandemic while also repositioning the company with key M&A and divestitures. The episode was sponsored by Clari. Go to Clair.com to learn about its unique revenue management platform. Chris Newmarker also delivers his Newmarker’s N ..read more
Visit website
DeviceTalks Boston is a Wrap – Gauging the impact of Big Pharma, AI, PE and other forces on Medtech
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
3w ago
In our closing session of DeviceTalks Boston, Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, sit down with two leaders in the field to break down the event and highlight some of the changes coming Medtech’s ways. Joe Mullings, CEO of the Mullings Group, and former J&J Medtech leader Peter Stebbins, now executive chairman of Nurami Medical, cover a broad range of topics on how will Big Pharma, AI, data, private equity and other external forces will impact the medical device industry. Are we going to see more roll ups from PE? Will a ne ..read more
Visit website
Free DeviceTalks Boston samples –VCs, Spine, Robotics, Career Advice and more – no toothpick needed
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
1M ago
Last call for DeviceTalks Boston! In this episode we'll preview our upcoming conference by talking with Paul Grand, CEO of Medtech Innovator, Rebecca Whitney, SVP at ZimView, Holly Scott and Joe Mullings at the Mullings Group. We'll have Fastball Pitches from two Medtech Innovator companies that will be presenting on May 10-11. Register at DeviceTalks.com. Use the code DTWeekly25 to save 25% Chris Newmarker delivers his #newmarkernewsmakers featuring 3M, Zimmer Biomet, Stryker, Medtronic and Casana, maker of a now FDA-approved smart toilet seat. Thanks for listening to the DeviceTalks Weekly P ..read more
Visit website
How Boston Scientific’s peripheral vascular group develops tools to keep smaller blood vessels open
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
1M ago
In this episode of Boston Scientific Talks, Boston Scientific's Cat Jennings, President of Peripheral Vascular, and Dave Knapp, VP of R&D, discuss how they are working together to develop new products and technologies that will help patients with peripheral vascular disease, and how they are leveraging data and analytics to drive innovation. They also share their perspectives on the challenges and opportunities in the medical device industry, the importance of diversity and inclusion in the workplace, and how Boston Scientific is positioning itself for future growth. Tune in to this episod ..read more
Visit website
DTWEEKLY: Cerenovus’ Mark Dickinson on building a neurovascular portfolio; early peek at DT Boston
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
1M ago
In this episode, Tom Salemi interviews Mark Dickinson, worldwide president at Cerenovus, the neurovascular business at Johnson & Johnson Medtech. Mark Dickinson shares his unique entry into the medical device industry, how he built his career at the global company, and what the company is doing to develop its devices to treat stroke patients. In addition, we’ll also have interviews with Paul Grand, CEO of Medtech Innovator, and Jeff Alvarez, chief strategy officer at Moon Surgical. Both will be speaking at DeviceTalks Boston on May 10-11. Go to DeviceTalks.com to register. This episode is ..read more
Visit website
BOSTONSCIENTIFIC: Drew Bomett discusses challenges of cybersecurity protection for medical devices
DeviceTalks by MassDevice
by DeviceTalks by MassDevice
1M ago
How concerned should you be about cybersecurity? And as an industry, how do we reduce the risk of using medical devices and potentially exposing our patients' personal data? In this episode, Drew Bomett, chief information security officer for Boston Scientific, discusses the importance of cybersecurity in the medical device industry and the unique challenges that come with securing medical devices, particularly when it comes to legacy products. Additionally, Bomett walks us through the impact of COVID-19 on cybersecurity and how Boston Scientific specifically approaches managing risks and thre ..read more
Visit website

Follow DeviceTalks by MassDevice on Feedspot

Continue with Google
Continue with Apple
OR